- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01493752
Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function and Platelet Reactivity in Hypercholesterolemics.
Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function, Platelet Reactivity in Hypercholesterolemics Without Known Cardiovascular Disease or Atherosclerosis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, EC1M 6BQ
- Barts & The London Medical School, William Harvey Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants will be between 18-80 years of age.
- They will be largely newly diagnosed patients with hypercholesterolemia (total serum cholesterol>6.0mmol/L or any elevation of total cholesterol, LDL cholesterol or triglycerides with a QRISK 2 score >15%).
- We will include patients with familial hypercholesterolemia. These patients in general will either be managed in primary care alone or will attend the clinic following referral from general practitioners for further investigation following routine health tests.
- In addition, patients who have been referred due to inability to tolerate statin treatment will be included.
- They will be recruited into the study if they are interested in taking part in research, do not have any exclusion criteria on screening and give their written informed consent.
Hypercholesterolemics will be screened by taking a medical history and physical examination, blood pressure measurement and urine sample taken to check for diabetes. The subject will continue his/her usual diet and exercise regime prior to diagnosis of hypercholesterolemia for purposes of this study. They will not be taking any additional vitamin or food supplements for the duration of the study.
Exclusion criteria
- A history of symptomatic ischemic heart disease (angina, previous myocardial infarction, acute coronary syndrome) or other known atherosclerosis.
- A history of heart failure NYHA class 2-4 or severe LV dysfunction LVEF<30% regardless of symptom status.
- Use of statins within 2 months of screening visit.
- A history of diabetes.
- Systemic autoimmune disease such as rheumatoid arthritis, connective tissue disease, or other conditions known to be associated with chronic inflammation such as inflammatory bowel disease.
- Any use of non steroidal anti-Inflammatory drugs, antiplatelet agents or steroids within two months of commencing study or likely future use required during the study.
- Subjects with any acute infection, or significant trauma (burns, fractures).
- Subjects who have donated > 500mls blood within 56 days prior to study medication administration.
- Anaemia with Hb <10g/dl, or any other known blood disorder or significant illness that may affect platelet function, and coagulation. Known essential hypertension on antihypertensive medication is not a contraindication.
- History of malignancy within the past 5 years other than non-melanoma skin cancer.
- Any current life threatening condition including severe chronic obstructive airways disease, HIV infection, life threatening arrhythmia that may prevent subject completing the study.
- Alcohol/drug abuse within the past 6 months of screening visit.
- Excess alcohol consumption as defined as regular weekly consumption of >28 units male and >21 units female. (Department of Health Guidelines)
- Use of an investigational device or investigational drug within 30 days or 5 half lives (whichever is longer) preceding the first dose of study medication.
- Any non stable dosing of ongoing medication regimens throughout the study trial.
- A history of chronic viral hepatitis (including presence of hepatitis B surface antigen or hepatitis C antibody or other chronic hepatic disorder.)
- Abnormal liver function due to acute or chronic liver conditions 3 x upper limit of normal at screening.
- Renal impairment with creatinine clearance (eGFR) of <50ml/min at screening.
- Pregnancy at time of screening or intention of getting pregnant during course of study.
- Current smokers or ex smokers who stopped smoking <3 months prior to administration of study medication.
- BMI <18.5 or > or = 40kg/m2.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Nitrate-rich beetroot juice
Six weeks once daily dose of nitrate rich beetroot juice
|
250mls daily beetroot juice
|
Placebo Comparator: Nitrate deplete beetroot juice
six weeks daily dose beetroot juice (nitrate deplete)
|
250mls daily beetroot juice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flow Mediated Dilatation (FMD)
Time Frame: 6 weeks
|
Brachial artery ultrasound FMD as a measure of endothelial function before and after beetroot juice
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Platelet aggregation studies, pulse wave analysis, pulse wave velocity, plasma nitrate and nitrate concentration.
Time Frame: after 6 weeks
|
after 6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11/LO/0715
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Provident Clinical ResearchGlaxoSmithKlineUnknownPrimary HypercholesterolemiaUnited States
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Sun Yat-sen UniversityActive, not recruiting
-
Organon and CoMerck Sharp & Dohme LLCCompleted
Clinical Trials on beetroot juice
-
Bangor UniversityCompleted
-
Universidad Francisco de VitoriaUniversity of Alcala; University of SevilleCompleted
-
University Hospital, GhentUniversity GhentTerminated
-
Queen Mary University of LondonCompleted
-
University of ManchesterCompleted
-
Wake Forest University Health SciencesCompletedStroke | Ischemic Stroke | Cerebrovascular AccidentUnited States
-
University of Colorado, BoulderRecruitingChronic Kidney DiseaseUnited States
-
Penn State UniversityActive, not recruitingMetabolic SyndromeUnited States
-
Universidad Autonoma de MadridUniversidad Politecnica de Madrid; Camilo Jose Cela UniversityCompletedNitrates | Nutrition | Physical Performance | Sport Physiology | Elite Athletes
-
University of ReadingNot yet recruitingPost MenopausalUnited Kingdom